Navigation Links
IPC The Hospitalist Company, Inc. to Report Second Quarter 2008 Financial Results
Date:7/29/2008

NORTH HOLLYWOOD, Calif., July 29 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that it will report results for its second quarter 2008 ended June 30, 2008 on Tuesday, August 12, 2008, after the market close.

A conference call to review the results will begin at 5:00 p.m. ET (2:00 p.m. PT) on August 12, 2008 and will be hosted by Adam Singer, Chairman, Chief Executive Officer, and Chief Medical Officer, Jeffery Taylor, President and Chief Operating Officer, and Devra Shapiro, Chief Financial Officer.

To participate in the conference call, please dial 877-440-5788 (USA) or 719-325-4897 (International). In addition, a dial-up replay of the conference call will be available beginning August 12, 2008 at 8:00 p.m. ET (5:00 p.m. PT) and ending on August 26, 2008. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International) Replay Passcode: 8240696.

A live web cast of the call will also be available from the Investor Relations section on the corporate web site at http://www.hospitalist.com. A web cast replay can be accessed on the corporate web site beginning August 12, 2008 at approximately 8:00 p.m. ET (5:00 p.m. PT) and will remain available until September 12, 2008.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national hospitalist physician group practic
'/>"/>

SOURCE IPC The Hospitalist Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...e remains unclear, researchers say , , W...suggests that enzyme replacement therapy can make ...ry disease, a rare illness that affects the kidney... linked to the lack of an enzyme that helps metabo...cause it boosts the risk for a stroke, heart attac...
(Date:12/2/2009)...a., Dec. 2 By now, most people hav...ttes continue to grow in popularity. And, the late...remiumEcigarette - the new single piece PremiumOne...ingly low price of $14.99. ,, "This new product...te at a very low price, before making a bigger inv...
(Date:12/2/2009)... Directors Represent Diverse Healthcare Stakeholde...ire/ -- The membership of the National Quality For...Directors and reappointed four current Board membe...f healthcare stakeholders, including consumers, pr...community healthcare. ,, The newly elected Boa...
(Date:12/2/2009).... 2 Independence Blue Cross (IBC) ...ith Lincoln Financial Group. IBC will be the prima...10,000 Lincoln Financial Group employees, retirees...oln plan offerings will include the PPO option and...I speak for all of us at Independence Blue Cross w...
(Date:12/2/2009)...s from the California Institute of Technology (Cal...e first time, the previously mysterious process by...re added by enzymes called ubiquitin ligases to pr...ns tag target proteins for destruction by protein-...t ubiquitin ligases build ubiquitin chains very ra...
Breaking Medicine News(10 mins):Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4
...s of steroids are more than twice as likely to hav...o not, say researchers based on findings of a rece...lammatory conditions of the skin, lungs, joints, d...ween 1993 and 1996 and 82,202 people who did not u...
...insulin is effective and well tolerated in patient...ides glycemic control comparable to a conventional...ts randomly received either inhaled insulin with b...htly lower for the inhaled insulin group and incre...
...humans than just for honey find researchers based ...enom was given to rats with advanced rheumatoid ar...uctions of tissue swelling on affected paws. Re...ssion of inflammatory genes, much like COX-2 inhib...
...ne of the most frequent causes of indigestion. Typ...g,// and respiratory problems in some cases. Smoki...he risk of acid reflux say researchers according t... than non-smokers. Those who routinely added salt ...
... have a risk of developing high blood pressure. Hi...rysms // in the eye, which are characteristic of ...n England shows good blood pressure control signif...ned about 1,150 patients with high blood pressure ...
...ows that high-doses of vitamin E supplements, coul...y death.// Vitamin E is one of 13 vitamins ess...n. On average, dietary intake of vitamin E is 10 i...amin E capsules typically contain 400 internationa...
Other Medicine News:
(Date:12/2/2009)... , CENTENNIAL, Colo., Dec. 2 ... providers of skin, bone and soft tissue allograft...argest processor of live cellular bone growth subs...y iconic symbol of hope as a float rider aboard th...Tournament of Roses Parade®. Manuel Salazar,...
(Date:12/2/2009)... , LAKE FOREST, Ill., Dec. 2 /PRNewswire...ding provider of clinical information and medicati...has acquired Salt Lake City-based TheraDoc, a clin...rveillance systems. TheraDoc,s two leading product...Assistant(TM), join Hospira,s expanding portfolio ...
(Date:12/2/2009)... , KNOXVILLE, Tenn., Dec. 2 /PRNewswire/ ...com ), a division of the nation,s largest provider... it has signed two contracts to provide teleradiol...Illinois. ,, An agreement signed with UpState C...ll allow TeamHealth Teleradiology to provide servi...
Breaking Medicine Technology:AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 1Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 2Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 3Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 4Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 5Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 6Bill 26amp 3B Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease 59870 7Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 1Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 2Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 3Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 4Oncolytics Biotech 28R 29 Inc Announces Investment in Private Biotechnology Company 14550 1Oncolytics Biotech 28R 29 Inc Announces Investment in Private Biotechnology Company 14550 2
...OYLESTOWN, Pa., June 20, 2007 /PRNewswire-FirstCal...tp://www.quigleypharma.com/">www.QuigleyPharma.com...ation announced today that it,has completed a foll...vels of a pro-inflammatory cytokine Interleukin-6 ...d that responding mice had,lower levels of serum I...
...AN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ -- ... company committed to,the discovery, development a...eatment of hepatitis and cancer, announced today t...nical development as an,orally-administered direct...C virus (HCV) infection. , "We have identified a s...
Other Medicine Technology:Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 2Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 3Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 4Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
Lehner-Utrata Capsulorhexis Forceps
Koch Capsulorhexis Forceps
Maloney Capsulorhexis Forceps
McPherson Angled Bipolar Forceps
Medicine Products: